Statement of Use

ARISTOTLE

StageZero Life Sciences Ltd.

Trademark/Service Mark Statement of Use

PTO- 1553
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88292678
LAW OFFICE ASSIGNED LAW OFFICE 103
EXTENSION OF USE NO
MARK SECTION
MARK mark
LITERAL ELEMENT ARISTOTLE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION (current)
NAME StageZero Life Sciences Ltd.
MAILING ADDRESS 30-70 East Beaver Creek Road
CITY Richmond Hill, Ontario
ZIP/POSTAL CODE L4B3B2
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
EMAIL XXXX
OWNER SECTION (proposed)
NAME StageZero Life Sciences Ltd.
MAILING ADDRESS 30-70 East Beaver Creek Road
CITY Richmond Hill, Ontario
ZIP/POSTAL CODE L4B3B2
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Steven A. Abreu
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@sunsteinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 03907/2002
CORRESPONDENCE INFORMATION (proposed)
NAME Steven A. Abreu
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@sunsteinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 03907/2002
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Medical diagnostic reagents and assays for testing blood for cancer; Medical diagnostic reagents and assays for testing blood for gastroenterology disorders, neurology disorders, cardiology disorders and autoimmune disorders; medical diagnostic test kits for Cancer screening
GOODS OR SERVICES KEEP ALL LISTED
FIRST USE ANYWHERE DATE 09/21/2021
FIRST USE IN COMMERCE DATE 09/21/2021
SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN0-209120179194-2021092 0134933363054_._5_Specime n_1.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\882\926\88292678\xml11 \SOU0002.JPG
SPECIMEN DESCRIPTION Image of an instructional package insert shipped with the goods, bearing the mark
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
REQUEST TO DIVIDE NO
PAYMENT SECTION
NUMBER OF CLASSES IN USE 1
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 100
TOTAL AMOUNT 100
SIGNATURE SECTION
DECLARATION SIGNATURE /James Howard-Tripp/
SIGNATORY'S NAME James Howard-Tripp
SIGNATORY'S POSITION Chief Executive Officer
DATE SIGNED 09/22/2021
SIGNATORY'S PHONE NUMBER 9056172742
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Wed Sep 22 14:49:09 ET 2021
TEAS STAMP USPTO/SOU-XXX.XXX.XXX.XXX
-20210922144909597330-882
92678-7818fdad94f713ddc51
24b9e3c8c22e7898987b68f2b
922ba975ee96cecbc3e4a2-DA
-49071479-202109211112207
86922



PTO- 1553
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:
MARK: ARISTOTLE(Standard Characters, see http://uspto.report/TM/88292678/mark.png)
SERIAL NUMBER: 88292678


OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: StageZero Life Sciences Ltd., having an address of
      30-70 East Beaver Creek Road
      Richmond Hill, Ontario, L4B3B2
      Canada
      Email: XXXX
Proposed: StageZero Life Sciences Ltd., having an address of
      30-70 East Beaver Creek Road
      Richmond Hill, Ontario, L4B3B2
      Canada
      Phone:
      Email: XXXX

The owner is submitting the following allegation of use information:

For International Class 005:
Current identification: Medical diagnostic reagents and assays for testing blood for cancer; Medical diagnostic reagents and assays for testing blood for gastroenterology disorders, neurology disorders, cardiology disorders and autoimmune disorders; medical diagnostic test kits for Cancer screening

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 09/21/2021, and first used in commerce at least as early as 09/21/2021, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) Image of an instructional package insert shipped with the goods, bearing the mark.

Original PDF file:
SPN0-209120179194-2021092 0134933363054_._5_Specime n_1.pdf
Converted PDF file(s) (1 page)
Specimen File1

Webpage URL: None Provided
Webpage Date of Access: None Provided

The applicant is not filing a Request to Divide with this Allegation of Use form. Correspondence Information (current):
      Steven A. Abreu
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@sunsteinlaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is 03907/2002.
Correspondence Information (proposed):
      Steven A. Abreu
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@sunsteinlaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is 03907/2002.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.


Declaration


The signatory believes that the applicant is the owner of the mark sought to be registered.
For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified.
For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified.
For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.



Signature: /James Howard-Tripp/      Date Signed: 09/22/2021
Signatory's Name: James Howard-Tripp
Signatory's Position: Chief Executive Officer
Signatory's Phone: 9056172742
Signature method: Sent to third party for signature

PAYMENT: 88292678
PAYMENT DATE: 09/22/2021

Serial Number: 88292678
Internet Transmission Date: Wed Sep 22 14:49:09 ET 2021
TEAS Stamp: USPTO/SOU-XXX.XXX.XXX.XXX-20210922144909
597330-88292678-7818fdad94f713ddc5124b9e
3c8c22e7898987b68f2b922ba975ee96cecbc3e4
a2-DA-49071479-20210921111220786922



Statement of Use [image/jpeg]

Statement of Use [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed